جستجوی استاد راهنمای دانشگاهی

برای مسیر پژوهشی‌تان، استاد راهنما، استاد دانشگاه و پژوهشگر مناسب را پیدا کنید و با آن‌ها ارتباط بگیرید.

نمایش ۱-۱۵ از ۳۳۸ استاد راهنما

اطلاعات پروفایل‌ها از صفحات عمومی دانشگاه‌ها گرفته شده و ممکن است به‌روز نباشد.

Amin Ardestaniمشاهده پروفایل

مدرس ارشد

University of HullUnited Kingdom

Dr Amin Ardestani , Senior Lecturer in Metabolic Signaling at the Biomedical Institute for Multimorbidity (BIM), Hull York Medical School (HYMS) , specializes in unraveling molecular mechanisms of pancreatic β-cell failure in diabetes. His research program identifies novel therapeutic targets through signal transduction studies in metabolic disorders. Bachelor's in Biology, Tarbiat Moalem University (2004) Master's in Biochemistry, Institute of Biochemistry and Biophysics (2007) PhD in Biology, University of Bremen (2013) Junior Group Leader at University of Bremen (2014-2023) Research focuses on Hippo and mTOR signaling pathways in β-cell biology, autoimmunity, and regeneration. His work bridges mechanistic biology with drug discovery for diabetes, with significant findings on PHLPP1/2 phosphatases and MST1/2 kinases. Recent publications highlight therapeutic strategies for β-cell protection , including small molecule inhibitors (e.g., MST1/2 inhibitors) and metabolic enzyme modulation (LDHA). Collaborative studies explore SARS-CoV-2 interactions with pancreatic cells and cross-talk between acinar and β-cells in diabetes. 2019 JDRF Advanced Postdoctoral Fellowship 2018 Impulse grant & Career Advancement Award 2017 Early Investigators awards (Endocrine Society, EFSD/Lilly Programme) 2014 Albert Renold Fellowship & Bremer Studienpreis Professional roles include Editorial Board Member at Scientific Reports and Associate Editor at Frontiers in Endocrinology . He reviews grants for DFG, Diabetes UK, and ISF, and evaluates manuscripts for top-tier journals like Cell Metabolism and Nature Communications.

پروفایل رسمی دانشگاه

Elisabeth Engel Lópezمشاهده پروفایل

استاد

Institute for Bioengineering of Catalonia (IBEC)Spain

Prof. Elisabeth Engel López leads the Biomaterials for Regenerative Therapies group at the Institute for Bioengineering of Catalonia (IBEC) and serves as a Professor at the Technical University of Catalonia. With over 80 publications in JCR journals, her work focuses on designing biomaterials and scaffolds for in vitro/in vivo regenerative medicine, emphasizing cellular response mechanisms and translational applications. Developing lactate-releasing systems for metabolic modulation Advancing 3D bioprinting for tissue-specific models Engineering angiogenic and osteogenic biomaterials Her research bridges fundamental studies with industrial partnerships, including pharmaceutical and biomedical device companies, and contributes to European collaborative projects. She received the Barcelona City Award for technological research and has delivered numerous invited lectures. Her group explores substrate stiffness, ion release, and microenvironmental cues to control cell behavior in cardiac, neural, and bone regeneration contexts.

پروفایل رسمی دانشگاه

Sergio Burgosمشاهده پروفایل

دانشیار

McGill UniversityCanada

Sergio Burgos, PhD is an Associate Professor in the Department of Animal Science at McGill University's Faculty of Agricultural and Environmental Sciences, and a Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC). He leads an interdisciplinary research program integrating animal nutrition, human health, and environmental sustainability. Pan-American School of Agriculture, Zamorano, Honduras (Agrónomo) University of Florida (BSc Animal Science) University of California, Davis (MSc Animal Science) University of Guelph (PhD Animal Science, 2009) Research Focus examines protein foods' roles in: Human Nutrition & Cardiometabolic Health Dairy Production Systems & Rumen Microbiome Milk Metabolomics & Bioactive Compounds Climate Impact Reduction through Dietary Transitions Publication Trends demonstrate: 2024-2025: Prioritization of plant-animal protein substitutions for climate & health 2020-2023: Mechanistic studies on amino acid regulation of mammary cell function 2016-2020: Foundational work on insulin resistance and dairy nutrition Awards Richard and Edith Strauss Postdoctoral Fellowship (2010-12) Professional Affiliations Regroupement OptiLAIT (2015-present) American Society for Nutrition (2015-present) Canadian Diabetes Association (2012-present) Teaches core courses in animal nutrition, protein metabolism, and computational ration balancing.

پروفایل رسمی دانشگاه

Xi-Long Zhengمشاهده پروفایل

استاد

University of CalgaryCanada

Xi-Long Zheng is a tenured Professor in the Department of Biochemistry and Molecular Biology and Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. He holds additional appointments as a Member of the Libin Cardiovascular Institute and Associate Member of both the Snyder Institute for Chronic Diseases and Arnie Charbonneau Cancer Institute. His research focuses on vascular smooth muscle biology and its role in cardiovascular diseases. Doctor of Medicine, Hunan Medical University (1986) M.S. in Pharmacology, Hunan Medical University (1989) Doctor of Philosophy in Pharmacology, University of Calgary (1997) Dr. Zheng's research centers on vascular smooth muscle cell differentiation, proliferation, and phenotypic switching in vascular diseases. His laboratory investigates mechanisms of vascular smooth muscle dedifferentiation in atherosclerosis, abdominal aortic aneurysms, and vascular stiffness. Current work explores ferroptosis, epigenetic regulation (particularly BRD4), and PCSK9 functions in vascular pathologies. His studies integrate molecular, cellular, and in vivo approaches to identify novel therapeutic targets for cardiovascular diseases. Analysis of his recent publications reveals strong emphasis on cell death mechanisms (ferroptosis, cuproptosis), epigenetic regulation, lipid metabolism, and immune-vascular interactions in atherosclerosis. His work demonstrates increasing focus on translational applications targeting vascular smooth muscle phenotypic switching and plaque stability. Alberta Innovates ‒ Health Solutions Senior Scholar Award (2008-2015) Heart & Stroke Foundation New Investigator Award (2001-2006) CIHR/Hypertension Society Scholarship Award (2001-2004) Heart & Stroke Foundation Fellowship Award (1999-2001) AHFMR Independent Investigator Award (2008) Dr. Zheng serves on grant panels for Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada. He is an editorial board member for Biochemical Journal and other scholarly publications. His laboratory receives funding from CIHR and NSERC for projects including smooth muscle PCSK9 in abdominal aortic aneurysm pathogenesis, smooth muscle autophagy in vascular aging, and epigenetic regulation of smooth muscle plasticity. The Zheng Lab investigates vascular smooth muscle functions across multiple organ systems including blood vessels, gastrointestinal tract, bladder, and uterus. His research has established critical mechanisms in vascular smooth muscle differentiation and cell cycle regulation, contributing over 100 peer-reviewed publications in high-impact journals including PNAS, ATVB, Diabetologia, JBC, and Hypertension.

پروفایل رسمی دانشگاه

Ramana V Davuluriمشاهده پروفایل

استاد

Stony Brook UniversityUnited States

Ramana V Davuluri serves as Professor in the Department of Biomedical Informatics at Stony Brook University's Renaissance School of Medicine. With over 20 years of experience in bioinformatics and computational genomics, he leads research at the intersection of machine learning and cancer genomics, focusing on translating high-dimensional -omic data into clinically actionable insights through statistically rigorous methodologies. Dr. Davuluri's research spans Machine Learning applications in Cancer Data Science , isoform-level gene regulation , and precision-medicine development. His lab pioneers bioinformatics solutions for genomic data interpretation, with emphasis on developing machine learning algorithms that convert NextGen sequencing outputs into experimentally testable discovery models. A core focus involves creating rapid biomarker identification systems from human tissue and blood samples through integrated computational-experimental approaches in systems biology. Analysis of his 2023-2025 publications reveals a dominant trend toward genomic foundation models (e.g., DNABERT variants), multi-omic cancer subtyping , and time-dependent therapeutic strategies for pediatric brain tumors and ovarian cancer. His work consistently bridges computational innovation with biological validation across diverse cancer types including glioma, lung adenocarcinoma, and high-grade serous carcinoma. As Principal Investigator for multiple multi-investigator and multi-site projects, Dr. Davuluri directs research integrating high-throughput experimental procedures with advanced data-mining techniques. His laboratory maintains strong collaborations across oncology, neuroscience, and immunology domains while developing genomics-based decision support systems for clinical translation. The Davuluri Lab employs a systems biology framework to develop novel informatics tools for precision oncology, with particular emphasis on translating genomic discoveries into clinical applications through biomarker discovery and therapeutic strategy optimization.

پروفایل رسمی دانشگاه

Christopher Vakocمشاهده پروفایل

استاد

Cold Spring Harbor LaboratoryUnited States

Christopher Vakoc is a Professor at Cold Spring Harbor Laboratory (CSHL), holding the Alan and Edith Seligson Professorship of Cancer Research and serving as Deputy Director of the Cancer Center. His work focuses on understanding how epigenetic dysregulation contributes to cancer pathogenesis, with particular emphasis on epigenetic dependencies and lineage plasticity. Dr. Vakoc's research investigates how transcription factors and chromatin regulators control gene expression in cancer cells. His lab employs high-throughput CRISPR-based genetic screens to identify critical epigenetic regulators in specific cancers. A significant finding from his work demonstrated that blood cancers are often vulnerable to targeting transcriptional coactivators like BRD4 and the SWI/SNF chromatin remodeling complex. His team showed that BRD4 inhibition has therapeutic effects in leukemia mouse models, leading to ongoing clinical trials. Analysis of Vakoc's recent publications reveals a strong focus on pancreatic cancer mechanisms, particularly basal-like identity and lineage plasticity. His work on the MED12-ΔNp63 interaction in pancreatic cancer represents a major breakthrough in understanding how cancer cells lose their original identity. Additionally, his research spans acute myeloid leukemia, sarcoma, lung cancer, and glioma, with consistent themes of epigenetic regulation and identification of novel therapeutic targets. Scientific awards recognizing his contributions include: Paul Marks Prize for Cancer Research AACR Outstanding Achievement in Cancer Research Award Pershing Square Sohn Prize Long Island Excellence in Healthcare Award (2023) Burroughs Welcome Fund Career Award for Medical Scientists Dr. Vakoc actively mentors numerous graduate students and postdoctoral fellows, with several former trainees now holding prominent positions in academia and industry. His research is supported by multiple grants including funding from the National Cancer Institute, Pershing Square Sohn Cancer Research Alliance, and National Institutes of Health. The Vakoc Laboratory serves as a hub for innovative cancer epigenetics research, employing cutting-edge CRISPR screening technologies to reveal new therapeutic opportunities across multiple cancer types.

پروفایل رسمی دانشگاه

Linda Huangمشاهده پروفایل

استاد

University of Massachusetts BostonUnited States

Linda Huang is a Professor in the Department of Biology at the University of Massachusetts Boston, where she also serves as the Graduate Program Director. Her expertise lies in cell biology, with a focused research program on meiosis and spore formation in the budding yeast Saccharomyces cerevisiae . Education: PhD in Biology, California Institute of Technology BS in Biology, University of California, Los Angeles, 1988 Education Abroad Program, University of Sussex, England, 1986–87 Research Interests: Linda Huang's research centers on understanding the molecular mechanisms of meiosis and gametogenesis using yeast as a model organism. Her lab investigates how cellular events during meiosis are coordinated, particularly focusing on the regulation of meiotic exit and spore morphogenesis. She employs genetics, molecular biology, and biochemistry to dissect signaling pathways such as the Cdc15-Sps1 cascade, which plays a critical role in cytokinesis and spindle disassembly during meiosis II. Her recent work has contributed to defining a non-canonical Hippo-like pathway that governs key events in meiotic progression, distinguishing it from mitotic regulation. This research has implications for understanding fundamental cell division processes and their regulation in eukaryotic cells. Publications and Contributions: Huang has authored numerous peer-reviewed articles in top-tier journals, focusing on yeast genetics, cell signaling, and meiotic regulation. Her work has been featured in journals such as Genetics , Molecular Biology of the Cell , and Journal of Fungi . She has also contributed to educational materials, including test banks for widely used biology textbooks.

پروفایل رسمی دانشگاه

Andrea Fossatiمشاهده پروفایل

استادیار

Uppsala UniversitySweden

Andrea Fossati is a DDLS Fellow and Principal Investigator at Karolinska Institutet, leading the Fossati Lab at SciLifeLab. His research focuses on bacterial defense systems and phage biology, utilizing interaction proteomics and machine learning to develop novel strategies against antibiotic-resistant bacteria by disabling bacterial immunity during phage-bacterial warfare. Dr. Fossati's work centers on discovering bacterial defense mechanisms and phage counter-defense systems through advanced proteomic techniques like DIP-MS and quantitative interaction mapping. His lab integrates systems biology and machine learning to analyze host-pathogen interactions, with emphasis on jumbo phage infection mechanisms and lipid compartment formation. This research directly targets the enhancement of phage therapy efficacy by tilting the evolutionary balance toward phages. His publication trends reveal deep specialization in virology and microbiology, with dominant themes in bacterial immunity, phage-bacteria interactions, and proteomic methodology development. Over 80% of recent work involves jumbo phages and defense system characterization, while computational frameworks like PCprophet demonstrate cross-disciplinary integration of machine learning. Scientific awards: DDLS Fellow Dr. Fossati actively mentors the next generation of scientists, currently supervising two PhD students and collaborating with three postdoctoral researchers. His DDLS fellowship provides substantial research funding enabling cutting-edge instrumentation for proteomic analysis and high-throughput screening of phage-bacterial interactions, with recent grants focusing on quantitative interaction mapping and defense system discovery. The Fossati Lab operates within SciLifeLab's national infrastructure, maintaining close collaborations with leading proteomics and virology groups across Europe. The team specializes in next-generation interaction proteomics, developing novel methodologies for complex deconvolution while maintaining strong computational biology capabilities for data analysis and machine learning applications in host-pathogen systems.

پروفایل رسمی دانشگاه

Peixin Yangمشاهده پروفایل

استاد

University of Maryland, BaltimoreUnited States

Dr. Peixin Yang is the Christopher R. Harman, MD Endowed Professor of Obstetrics, Gynecology, and Reproductive Sciences at the University of Maryland School of Medicine. He serves as Professor with tenure in the Department of Obstetrics, Gynecology and Reproductive Sciences and holds a secondary appointment in the Department of Biochemistry & Molecular Biology. Dr. Yang is the founding director of the Center for Birth Defect Research at the University of Maryland School of Medicine and leads multiple NIH-funded research projects totaling millions of dollars. Dr. Yang's educational background includes: B.S. in Animal Science from Zhejiang Agricultural University (1986-1990) M.S. in Animal Reproductive Sciences from Nanjing Agricultural University (1990-1993) Ph.D. in Biophysics from Tokyo University of Agriculture & Technology and Zhejiang University (1994-1999) Postdoctoral Research Associate at University of Nebraska Medical Center (1999-2002) BIRCWH scholar (NIH K12) at University of Maryland Baltimore (2008-2009) Dr. Yang has built an extensive research program focused on diabetic embryopathy, particularly examining how maternal diabetes induces neural tube defects (NTDs), congenital heart defects (CHDs), and kidney defects. His laboratory was the first to establish a mouse model of diabetic embryopathy and reveal the causal role of JNK1/2 in neural tube defects. He has made significant contributions to understanding the molecular mechanisms of cellular stress, endoplasmic reticulum stress, and autophagy in neural tube defect formation. Dr. Yang also investigates the effects of maternal obesity on placental function and has established the Maryland Maternal Health Research Center of Excellence. His recent work has expanded to include studies on SARS-CoV-2 infection in pregnancy and connections between insulin resistance signaling and Alzheimer's disease. Analysis of Dr. Yang's recent publications reveals a strong focus on the molecular mechanisms of diabetic embryopathy, with particular emphasis on epigenetic regulation, cellular stress signaling pathways, and placental function. His work consistently bridges basic science with clinical applications, developing potential therapeutic approaches for preventing birth defects. A significant portion of his recent research examines the intersection of maternal metabolic conditions (diabetes and obesity) with fetal development, while also expanding into novel areas like viral infections in pregnancy and connections to neurodegenerative diseases. Dr. Yang's notable scientific achievements include: The F. Clarke Fraser New Investigator Award from the Teratology Society (2013) BIRCWH scholar (NIH K12) (2008-2009) The Lalor foundation postdoctoral Fellowship (2002-2003) Dr. Yang currently directs a multi-million dollar NIH-funded research group with multiple active R01 grants. His current projects investigate the intersection of mTOR/p70S6K1 signaling and HIPPO-Yap tissue organizer in neurulation, heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy, hyperglycemia-induced cardiac progenitor dysfunction, and epitranscriptomic alterations in diabetic embryopathy. He has developed a robust research program in maternal diabetes-induced heart defects, which was previously an understudied area. Dr. Yang is also leading efforts to establish the Maryland Maternal Health Research Center of Excellence, focusing on the adverse effects of obesity, placental accreta spectrum, and opioid use disorder. As the founding director of the Center for Birth Defect Research at the University of Maryland School of Medicine, Dr. Yang leads a multidisciplinary team of translational and clinical scientists. His laboratory has made original contributions to understanding the molecular mechanisms underlying maternal diabetes-induced structural birth defects. The team employs genetically modified mouse models, whole-embryo culture systems, and human placental studies to investigate the effects of metabolic conditions on fetal development. Dr. Yang's group has been instrumental in developing natural compounds as potential preventatives for diabetic embryopathy, including trehalose, epigallocatechin-3-gallate, and curcumin.

پروفایل رسمی دانشگاه

Amy Cherie Ralstonمشاهده پروفایل

استاد

Michigan State UniversityUnited States

Amy Cherie Ralston is a Professor at Michigan State University's College of Natural Science in the Department of Biochemistry & Molecular Biology , where she also serves as Associate Dean - Graduate Studies . Her research focuses on the genetic and molecular mechanisms governing early mouse embryonic development, particularly the specification of pluripotent and extraembryonic lineages. Education: Ph.D. in Zoology, University of Wisconsin (2004) B.A. in Biochemistry, Oberlin College (1995) Research Interests encompass mouse embryonic development, pluripotent stem cell regulation, HIPPO signaling pathway functions, and transcription factor dynamics during lineage specification. She has extensively studied the roles of OCT4, SOX2, Cdx2, and TEAD4 in developmental fate determination. Publications highlight trends in mouse blastocyst lineage segregation, stem cell maintenance mechanisms, and signaling pathway interactions. Notable work includes studies on HIPPO pathway members' restriction of pluripotency factors and culture condition impacts on developmental signaling. Students and Lab : Dr. Ralston leads the Ralston Laboratory, mentoring graduate and postdoctoral researchers in developmental biology and stem cell research. While specific student names aren't listed, her lab's work has produced significant insights into extraembryonic endoderm stem cell lines and transcription factor functions in reprogramming.

پروفایل رسمی دانشگاه

Kang Chenمشاهده پروفایل

استاد

Wayne State UniversityUnited States

Professor Kang Chen is a faculty member at the Wayne State University School of Medicine with joint appointments in the Department of Obstetrics and Gynecology , Biochemistry, Microbiology and Immunology , Oncology , and the Center for Molecular Medicine and Genetics . He co-chairs the Immunology Focus Group across Wayne State University, Karmanos Cancer Institute, and Henry Ford Health. PhD : Weill Cornell Medicine, Memorial Sloan-Kettering Cancer Center, Hospital for Special Surgery BSc (First-Class Honours): National University of Singapore Dr. Chen's research focuses on immune regulation of cancer , reproductive disorders , and mucosal immunity . His lab investigates antibody diversification mechanisms in B cells, immunoglobulin class switching and somatic hypermutation dysregulation in diseases, and maternal-fetal immune interactions affecting pregnancy outcomes. Recent publications highlight his work on WWC proteins in tumor suppression (2025), gene therapy for mesothelioma (2024), IgD-basophil interactions (2023), Maspin in cancer stem cell regulation (2022), and preterm labor immunoprotection (2017). His studies span immunology , oncology , and reproductive medicine . Scientific Awards American Association of Immunologists Travel Awards (2023, 2025) College Teaching Awards (2020, 2017) Research Excellence Award (2016) Burroughs Wellcome Fund Investigator (2014) NIH MIST Young Investigator Award (2013) Dr. Chen teaches Immunology , Cancer Immunotherapy , and Reproductive Biology courses at Wayne State University. His lab collaborates with academic and clinical partners across institutions, leveraging molecular, cellular, and animal model approaches to develop novel therapeutics for cancer and immune-related reproductive disorders. As principal investigator, he leads studies on maternal-fetal immune crosstalk , antibody diversification , and mucosal immunology , with patents in therapeutic antibody generation and preterm labor prevention .

پروفایل رسمی دانشگاه

Harold A. Singerمشاهده پروفایل

استاد

Albany Medical CollegeUnited States

Dr. Harold A. Singer is a Professor and Chair in the Department of Molecular and Cellular Physiology at Albert Einstein College of Medicine. His research focuses on calcium signaling mechanisms in vascular smooth muscle cells, particularly the role of CaMKII isoforms in regulating gene transcription and vascular remodeling. Research spans vascular biology , signal transduction , and cardiovascular pathophysiology Key interests include CREB phosphorylation , CaMKIIδ function , and vessel injury responses His recent work examines CaMKII-endothelium interactions in re-endothelialization and angiogenesis . Grants from the NIH (R01 HL049426, R01 HL092510) support his investigations into vascular remodeling and disease mechanisms .

پروفایل رسمی دانشگاه

Lois Mulliganمشاهده پروفایل

استاد

Queen's University at KingstonCanada

Lois Mulligan is a Professor in the Department of Pathology and Molecular Medicine at Queen's University. She holds cross-appointments in Pediatrics, Biomedical and Molecular Sciences, and is a Principal Investigator at the Queen's Cancer Research Institute. Her research focuses on the molecular mechanisms of the RET receptor tyrosine kinase in cancer, particularly thyroid, adrenal, and pancreatic tumors. She has expertise in molecular and cellular biology, protein manipulation, and confocal microscopy. Education includes a PhD in Medical Genetics from Queen's University (1993), post-doctoral training in cancer genetics at the Ludwig Institute (1990), and a Doctorate in Human Genetics (1986). She teaches courses in experimental cancer therapeutics and cancer biology. Mulligan's research investigates how RET dysregulation contributes to oncogenesis, with a focus on isoform-specific signaling, membrane dynamics, and therapeutic targets. Recent work includes studies on TMEM127 tumor suppression and GFRα ligand interactions. Her lab uses models like 3D spheroids and CRISPR screens to dissect RET pathways. Affiliations include the Queen's Cancer Research Institute and Endocrine-Related Cancer journal. Her work bridges basic science and translational oncology, emphasizing personalized medicine approaches.

پروفایل رسمی دانشگاه

Michal Hegerمشاهده پروفایل

پژوهشگر

Utrecht UniversityNetherlands

Dr. Michal Heger is a Researcher at Utrecht University's Faculty of Science, specifically within the Membrane Biochemistry & Biophysics department. He also holds the position of Professor of photonanomedicine at Jiaxing University Medical College in China and serves as Editor-in-chief of the Journal of Clinical and Translational Research. Additionally, he is Chief formulation officer at Nurish.Me in San Diego. Dr. Heger's research primarily focuses on the development of minimally invasive diagnostic and therapeutic modalities for treatment-resistant cancers, with special emphasis on bile duct cancer (extrahepatic cholangiocarcinoma, eCCA). His work follows three pillars: minimally invasive approaches, patient-friendly treatments, and affordable solutions. Photodynamic therapy (PDT) forms the core of his research program, where he investigates nanoscale carrier platforms for photosensitizer delivery, cancer cell responses to PDT, PDT-induced immune responses, and representative cell and animal models for cholangiocarcinoma. His publication record shows significant expertise in photodynamic therapy, with numerous articles spanning from 2012 to 2025. The research trends indicate a strong focus on nanotechnology applications in cancer therapy, particularly in developing targeted delivery systems for photosensitizers and combination therapies. His work bridges basic science with clinical applications, especially in difficult-to-treat cancers where conventional approaches have limited success. Dr. Heger collaborates extensively with various research groups, particularly in the areas of liquid biopsies and molecular profiling for cancer diagnostics and therapy monitoring. His work often involves interdisciplinary approaches combining pharmacology, nanotechnology, and molecular biology to address challenging clinical problems in oncology.

پروفایل رسمی دانشگاه

Md. Abul Hassan Sameeمشاهده پروفایل

دانشیار

Baylor College of MedicineUnited States

Md. Abul Hassan Samee is an Associate Professor at Baylor College of Medicine , specializing in Integrative Physiology . He is affiliated with the Computational and Integrative Biomedical Research Center (CIBR) , THINC@BCM , and the Cardiovascular Research Institute (CVRI) . Education: Postdoctoral Fellowship at Gladstone Institutes, University of California San Francisco PhD in Computer Science from University of Illinois Urbana Champaign Research Interests: Development of machine learning algorithms for biological datasets Single-cell and spatial omics analysis Comparative genomics in regeneration and aging Computational models for cancer and neurodegenerative diseases Publications focus on spatial transcriptomics, cardiac regeneration, and interpretable AI in genomic research. Recent projects include SPaSE for pathology scores and GraphAge for epigenetic aging. Grants from the National Institutes of Health support his work on Alzheimer's disease and MYH7 variant interpretation.

پروفایل رسمی دانشگاه